FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022242014> ?p ?o ?g. }

• W3022242014 endingPage "393" @default.
• W3022242014 startingPage "375" @default.
• W3022242014 abstract "Ruxolitinib (Jakafi, Jakavi, Incyte, Novartis) is a cyclopentylproprionitrile derivative tyrosine kinase inhibitor (TKI) that targets with high selectivity a new class of tyrosine kinases represented by JAK1 and JAK2, which are inhibited at IC50 of 3.3 and 2.8 nM, respectively. Lower activity is expressed by this drug on TYK2 (19 nM), and much lower on JAK3 (428 nM). In fact, this TKI was designed to spare JAK3 to avoid impairing lymphopoiesis. In 2011, the Food and Drug Administration (FDA) granted approval for the treatment of intermediate-2 or high-risk myelofibrosis (MF), primary myeloproliferative disorder (PMF), post-polycythemia vera myelofibrosis (PPVMF), and post-essential thrombocytopenia myelofibrosis (PETMF). The European Medicines Agency (EMA) approved ruxolitinib in 2012 for the treatment of disease-related splenomegaly, or symptoms in adult patients with PMF, PPVMF, or PETMF. Subsequently, the FDA (December 2014) and EMA (January 2015) extended the treatment to polycythemia vera patients, after an inadequate response or intolerance to hydroxyurea. The initial safety profile in MF patients was based on 301 exposed patients in Phase III INCB-351 and INCB-352 trials. The integrated database consisted of 617 patients (455 with MF) exposed to ruxolitinib, most of whom had been unsuccessful with other therapies. The safety profile is characterized by myelosuppression, mainly expressed as thrombocytopenia, anemia, and neutropenia; and nonhematologic events, such as cephalea, dizziness, and bruising. Other events of relevance are immunosuppression, as manifested by the increased frequency of infections, including tuberculosis, viral infections and reactivations, opportunistic infections, and progressive multifocal leukoencephalopathy; risk of nonmelanoma skin cancer, lipase elevation, and the ruxolitinib withdrawal syndrome consisting of symptomatic disease exacerbation expressed as acute respiratory distress syndrome, pyrexia, hypotension, disseminated intravascular coagulation, and multiorgan failure." @default.
• W3022242014 created "2020-05-13" @default.
• W3022242014 creator A5001706013 @default.
• W3022242014 date "2017-01-01" @default.
• W3022242014 modified "2023-09-26" @default.
• W3022242014 title "Ruxolitinib" @default.
• W3022242014 cites W1607057462 @default.
• W3022242014 cites W1893900021 @default.
• W3022242014 cites W1966669762 @default.
• W3022242014 cites W1968931030 @default.
• W3022242014 cites W1969658638 @default.
• W3022242014 cites W1974435279 @default.
• W3022242014 cites W1976651396 @default.
• W3022242014 cites W1977061684 @default.
• W3022242014 cites W1980568348 @default.
• W3022242014 cites W1981098678 @default.
• W3022242014 cites W1989356964 @default.
• W3022242014 cites W1990223118 @default.
• W3022242014 cites W1993934088 @default.
• W3022242014 cites W1995162107 @default.
• W3022242014 cites W1997682711 @default.
• W3022242014 cites W1999000517 @default.
• W3022242014 cites W2006467209 @default.
• W3022242014 cites W2007195093 @default.
• W3022242014 cites W2009114635 @default.
• W3022242014 cites W2011802318 @default.
• W3022242014 cites W2012686883 @default.
• W3022242014 cites W2013425721 @default.
• W3022242014 cites W2015963323 @default.
• W3022242014 cites W2018254868 @default.
• W3022242014 cites W2018276789 @default.
• W3022242014 cites W2018876713 @default.
• W3022242014 cites W2020294706 @default.
• W3022242014 cites W2021705314 @default.
• W3022242014 cites W2023680965 @default.
• W3022242014 cites W2023809476 @default.
• W3022242014 cites W2029818817 @default.
• W3022242014 cites W2033459852 @default.
• W3022242014 cites W2035817785 @default.
• W3022242014 cites W2036008068 @default.
• W3022242014 cites W2036685480 @default.
• W3022242014 cites W2037845887 @default.
• W3022242014 cites W2042563856 @default.
• W3022242014 cites W2043993681 @default.
• W3022242014 cites W2044155269 @default.
• W3022242014 cites W2045163297 @default.
• W3022242014 cites W2047079934 @default.
• W3022242014 cites W2047323080 @default.
• W3022242014 cites W2049804077 @default.
• W3022242014 cites W2050860213 @default.
• W3022242014 cites W2051181798 @default.
• W3022242014 cites W2051887590 @default.
• W3022242014 cites W2054787206 @default.
• W3022242014 cites W2057142301 @default.
• W3022242014 cites W2060328591 @default.
• W3022242014 cites W2063142212 @default.
• W3022242014 cites W2066214315 @default.
• W3022242014 cites W2066453038 @default.
• W3022242014 cites W2067092722 @default.
• W3022242014 cites W2071045462 @default.
• W3022242014 cites W2072279966 @default.
• W3022242014 cites W2075490622 @default.
• W3022242014 cites W2079645940 @default.
• W3022242014 cites W2081868440 @default.
• W3022242014 cites W2083073031 @default.
• W3022242014 cites W2083490754 @default.
• W3022242014 cites W2083736769 @default.
• W3022242014 cites W2085148377 @default.
• W3022242014 cites W2086582426 @default.
• W3022242014 cites W2086740979 @default.
• W3022242014 cites W2087172868 @default.
• W3022242014 cites W2087327268 @default.
• W3022242014 cites W2102365935 @default.
• W3022242014 cites W2105235256 @default.
• W3022242014 cites W2112242000 @default.
• W3022242014 cites W2113011422 @default.
• W3022242014 cites W2114995805 @default.
• W3022242014 cites W2115351357 @default.
• W3022242014 cites W2115400483 @default.
• W3022242014 cites W2117026298 @default.
• W3022242014 cites W2117206679 @default.
• W3022242014 cites W2117215550 @default.
• W3022242014 cites W2121305487 @default.
• W3022242014 cites W2121743767 @default.
• W3022242014 cites W2122395736 @default.
• W3022242014 cites W2123633897 @default.
• W3022242014 cites W2127929077 @default.
• W3022242014 cites W2131666890 @default.
• W3022242014 cites W2134540087 @default.
• W3022242014 cites W2136157904 @default.
• W3022242014 cites W2140319141 @default.
• W3022242014 cites W2141176110 @default.
• W3022242014 cites W2142506642 @default.
• W3022242014 cites W2143057570 @default.
• W3022242014 cites W2151734278 @default.
• W3022242014 cites W2152883117 @default.
• W3022242014 cites W2153832202 @default.
• W3022242014 cites W2156484880 @default.

• next